Interventional
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
anti hepatitis B antibodies
3 month
No
Israel: Ministry of Health
3097
NCT00863187
February 2009
Name | Location |
---|